Charles River launches first CRISPR-generated immunodeficient model – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
Charles River launches first CRISPR-generated immunodeficient model
OutSourcing-Pharma.com According to the company, the NCG model was developed by altering the Prkdc and Il2rg genes and is the company's first CRISPR-generated immunodeficient model offering. Charles River previously announced its “end-to-end” service offering of … |
